Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers

Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-10-20

The CE mark clears Medtronic to sell conduction system pacing therapy devices in Europe.

Source: MedTech Dive